Tsuchikawa Takahiro, Hirano Satoshi, Tanaka Eiichi, Kato Kentaro, Matsumoto Joe, Noji Takehiro, Shichinohe Toshiaki
Hepatogastroenterology. 2013 Sep;60(126):1360-4.
BACKGROUND/AIMS: There have been few papers on how to treat hepatobiliary malignancies after ERCP-related pancreatitis focusing on the timing of the operation and postoperative complications. The aim of this study was to clarify the relationship among the time after the pancreatitis, the complexity of the operation, and the characteristic postoperative complications.
The clinicopathological characteristics of five patients with hepatobiliary malignancies who had a prior history of ERCP-related pancreatitis were analyzed.
The five patients included two with extrahepatic bile duct carcinomas, two with ampulla of Vater carcinomas, and one with intrahepatic hilar cholangiocarcinoma. The median time to the operation from pancreatitis was 31 (16-116) days. The median operation time and blood loss were 661 (576-924) min and 3695 (2730-7240) mL, respectively. Various postoperative complications were seen in all cases including acute respiratory distress syndrome and infection of peripancreatic necrosis. The postoperative mortality rate was 0%, with a morbidity rate of 100%. R0 operations were performed in all five cases.
Surgery for hepatobiliary malignancies after ERCP-related pancreatitis appears to have a high morbidity rate. The surgery must strike a balance between curability of the malignancy and safety with respect to the frequent postoperative complications.
背景/目的:关于如何治疗内镜逆行胰胆管造影术(ERCP)相关胰腺炎后的肝胆恶性肿瘤,尤其是手术时机和术后并发症的研究较少。本研究旨在阐明胰腺炎后的时间、手术复杂性和术后特征性并发症之间的关系。
分析5例有ERCP相关胰腺炎病史的肝胆恶性肿瘤患者的临床病理特征。
5例患者中,2例为肝外胆管癌,2例为 Vater 壶腹癌,1例为肝门部胆管癌。胰腺炎后至手术的中位时间为31(16 - 116)天。中位手术时间和失血量分别为661(576 - 924)分钟和3695(2730 - 7240)毫升。所有病例均出现各种术后并发症,包括急性呼吸窘迫综合征和胰周坏死感染。术后死亡率为0%,发病率为100%。所有5例均进行了R0手术。
ERCP相关胰腺炎后肝胆恶性肿瘤手术的发病率似乎较高。手术必须在恶性肿瘤的可治愈性和频繁术后并发症的安全性之间取得平衡。